AmDTx is personalised for every patient. Because more than anything else, the brain is what makes us all unique.
AmDTx’s training is measured, promoting higher engagement and better outcomes through objective and benchmarked quantification of wellbeing. Scalable, easy to use, without a wearable.
AmDTx is available world-wide in six languages (and counting). Administering indication-specific and client-specific content and features, from cancer survivorship and concussion to employee performance, anxiety and rehabilitation.
Certified as a CE-Marked Class I Medical Device.
Clinical Risk Management Plan (CRMP)
Clinical Risk Management System (CRMS)
Clinical Safety Case Report
Clinical Safety Hazard Log
Mobio Interactive's digital theragnostic platform "AmDTx" is CE MDD Class I certified; GDPR-, HIPAA- and PHIPA-compliant; and undergoing certification for DCB0129, CE MDR Class IIa, ISO 13485, ISO 9000, ISO 82304 and ISO 27001.
Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, AmDTx.
Effective and accessible healthcare for every human.